Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline patient demographics

From: Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Number of patients 25
Age, y
 Median 67
 Min-max 43–89
Sex, n (%)
 Male 17 (68.0)
 Female 8 (32.0)
Extent of disease, n (%)
 MIBC 4 (16.0)
 mBCa 21 (84.0)
Prior chemotherapy, n (%) 15 (60.0)
Follow-up status, n (%)
 Deceased 11 (44.0)
 Alive 8 (32.0)
 No follow-up 6 (24.0)
Median days to blood draw 1075
Survival after CTC draw, days
 Median 167
 Min-max 40–599
  1. Abbreviations: Y, years, Min, minimum, Max, maximum, n, number of patients per category